Unfortunately we don't know if they have a proprietary MYC inhibitor or not - they might have one and are just playing with it. There is no obligation to tell us - it's a judgement call as to whether that would be price sensitive or not. Share prices of specs reflect so many things and only one of them is what is actually going on within the company - mostly they reflect investors/traders perceptions of that reality. If it turns out they create enormous value in the 2nd half of the year then it would be great if the SP reflected a linear path to that value but usually they just languish until a release and then rerate.
PYC Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)